3745 results for «2019»

Filter By

3745 results

PCR e-Course 2020 Late-Breaking Trials - part 2

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice: 

  • 2-year safety of revascularisation deferral based on iFR or FFR
  • CABG and PCI in patients with CTO and multivessel disease
  • Routine revascularisation vs. medical therapy
PCR e-Course 2020 Late-Breaking Trials

PCR e-Course Hot Lines in STEMI interventions: First-in-Man and novel pharmacological strategies

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines in STEMI interventions presented during PCR e-Course 2020, followed by an analysis of these results and their impact on your practice: MOCA I Study, ON-TIME 3 trial, FABOLUS FASTER.

STEMI interventions: First-in-Man and novel pharmacological strategies

PCR e-Course Hot lines: drugs and devices for STEMI management

Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.

Hot line: drugs and devices for STEMI management

Physiology or intracoronary imaging; or both? or none? - part 1

27 Jun 2020 – From PCR e-Course 2020

Watch a series of studies on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SCAAR report, a sub-analysis of the FORZA trial, diagnostic accuracy of IVUS-based FFR.

Physiology or intracoronary imaging; or both? or none?

Crossover results from the RADIANCE-HTN SOLO trial

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to learn about latest results from RADIANCE-HTN SOLO cohort and to review blood pressure results following crossover to ultrasound RDN in patients originally randomised to the sham arm in RADIANCE-HTN SOLO.

Videos included on this page: the Hot Line presentation, an...

Latest evidence from the RADIANCE-HTN trial and the path to clinical adoption

PCR e-Course 2020 Hot line: left atrial appendage closure

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on LAA closure presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: LAA occlusion vs. NOAC, Amulet IDE Roll-in cohort, identification of potential LAAC candidates.

PCR e-Course Hot lines: left atrial appendage closure

Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?

25 Jun 2020 – From PCR e-Course 2020

Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.

Videos included on this page: the abstract presentation and an Investigator Perspective.

Paclitaxel DEB for coronary lesions: 12-month results of the PREVAIL study

Physiology or intracoronary imaging; or both? or none? - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SOCT-PCI Study, impact of PPG index on PCI, angiography-derived IMR.

Physiology or intracoronary imaging; or both? or none?

Hot line on PCI: high bleeding risk and DAPT - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: TWILIGHT CHINA, SMART-CHOICE, LEADERS FREE III.

Hot lines on PCI: high bleeding risk and DAPT

PICSO improves coronary microvascular function in patients with STEMI

25 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to learn about the latest OxAMI-PiCSO study clinical results and to learn about the first-in-man of PiCSO in inferior STEMI patients.

Videos included on this page: the Hot Line presentation, an Investigator Perspective and a Wrap Up discussion.

Latest experience with PiCSO in STEMI patients

Controversies in antiplatelet therapy for secondary prevention of coronary artery events

26 Jun 2020 – From PCR e-Course

Watch this session if you want to understand more about the guidelines for antiplatelet secondary prevention of ACS/PC and to review available data on antiplatelet therapy after ACS/PCI.

Controversies in Antiplatelet Therapy for the Secondary Prevention of Cardiovascular Events

Ultrathin-strut vs. thin-strut DES for primary PCI

27 Jun 2020 – From PCR e-Course 2020

Watch this session to review the role of ultrathin DES in optimising clinical outcomes for STEMI patients, to assess the impact of the BIOSTEMI trial to daily practice and to learn about real-world challenges when treating STEMI patients.

Videos included on this page: the Hot Line presentation...

Ultrathin-strut vs. thin-strut DES for primary PCI

Are Lower MR Grades Within Our "Clasp"? – PASCAL Repair System Experience

Watch this session to know more about the transcatheter PASCAL Repair System for the treatment of mitral regurgitation and its clinical and commercial experience.

Are Lower MR Grades Within Our 'Clasp'? – PASCAL Repair System Experience

Pharmacological treatment of SARS-CoV2: ongoing and planned clinical trials

25 Jun 2020 – From PCR e-Course 2020

In this video, Philippe Gabriel Steg provides an in-depth review of ongoing and planned clinical trials for the pharmacological treatment of SARS-CoV2 (COVID-19), as well as discussing some of the challenges linked to these trials, particularly the methodological challenges: enrollment window, ethical questions, which outcomes to...

Pharmacological treatment of SARS-CoV2: ongoing and planned clinical trials

The year in intervention: essential publications from EuroIntervention and the European Heart Journal

27 Jun 2020 – From PCR e-Course 2020

Watch this video to find out what were the most essential, impactful and influential papers published in EuroIntervention and the European Heart Journal over the past year, and learn more about the academic versus social impact of citations.

The year in intervention: essential publications from EuroIntervention and the European Heart Journal

Abstracts on stent & scaffolds - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of abstracts from PCR e-Course 2020 on the topic of Stents & scaffolds:

  • 12-month follow-up results of the first cohort of the BIOSOLVE-IV registry
  • The effects of shockwave lithotripsy on DES
  • 5-year data of the drug-eluting absorbable metal scaffold in BIOSOLVE-II
  • Bailout stenting post drug coated balloons;...
Abstracts on Stent & scaffolds - PCR e-Course 2020

PCR e-Course 2020 Clinical cases

25 Jun 2020 – From PCR e-Course 2020

Watch a series of best clinical cases presented at the PCR e-Course 2020:

  • ACS-patient with culprit in a coronary ectasia
  • Coronary stenting in an ectatic artery
  • Challenging PCI after aortic valve-in-valve implantation
  • Cisplatin-induced coronary artery thrombosis presented as ACS
  • MOCA I study: microvascular obstruction measured using dMVR
  • The many faces of in-stent...
PCR e-Course Clinical cases

Merits of revascularisation and medical treatment in patients with chronic coronary syndromes

26 Jun 2020 – From PCR e-Course 2020

The main objectives when treating patients with chronic coronary syndromes are to reduce the risk of death and ischaemic events, and to improve the quality of life. Find out more on the role of medical treatment and revascularisation to achieve these goals.

This state-of-the-art lecture was originally...

Merits of revascularisation and medical treatment

How to understand the ISCHEMIA trial?

27 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to get a better understanding of what the ISCHEMIA trial is about and what it is not about, and to make up your own opimind on the strength of the ISCHEMIA conclusions based on its methodology and results.

This session was...

How to understand the ISCHEMIA trial?

Treating tricuspid regurgitation with the PASCAL repair system

Watch this roundtable discussion on the treatment of tricuspid regurgitation with the recently approved in Europe PASCAL Repair System.

Treating tricuspid regurgitation with the PASCAL repair system
Didn’t find what you were looking for?